Evotec erforscht Wirkstoffe für neue Arzneien unter anderem gegen Alzheimer, Krebs oder Diabetes. Partner sind dabei Pharma- und Biotechnologieunternehmen. Sitz ist in Hamburg.
COMPANY
INVESTOR TERMSHEET
EVT
Evotec
#BGFL Mood:
Neutral
·
#BGFL-Indicator:
Hold
·
Review date:
-
LEI:
529900F9KI6OYITO9B12
SECTOR:
Gesundheit
SUB-SECTOR:
Biotechnologie
Evotec
566480
DE0005664809
EVT
MDAX
Xetra
#BGFL-nes Evotec: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.
08.09.2014 | Evotec: Abgründe tun sich auf |
02.09.2013 | Evotec: US-Investor ist begeistert von dem TecDAX-Wert |
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL